Gael Roué (G Roué, Gael Roue, Gaël Roué)

ResearcherID Loop profile ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Venues

Cancers

Cells

Cancer research communications

Leukemia & lymphoma

Josep Carreras Leukaemia Research Institute

Université de Caen Faculté de Médecine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Josep Carreras Leukaemia Research Institute Nov 01 2019

Spain

Group Leader :: Lymphoma Translational Group

Vall d´Hebron Institut d´Oncologia May 01 2017 - Oct 31 2019

Spain

Senior Scientist :: Experimental Hematology

Hospital Vall d'Hebron May 01 2017 - Oct 31 2019

Spain

Lab specialist :: Hematology

Institut d'Investigacions Biomèdiques August Pi i Sunyer Feb 01 2008 - Jan 31 2017

Spain

Tenure Track Investigator :: Hemato-Oncology

Education History

Université de Caen Faculté de Médecine Sep 01 1999 - Jun 30 2002

France

PHD

Publications

Ignacio Campillo-Marcos, Marta Casado-Pelaez, Veronica Davalos, Gerardo Ferrer, Caterina Mata, Elisabetta Mereu, Gael Roué, David Valcarcel, Antonieta Molero, Lurdes Zamora, Blanca Xicoy Cirici, Laura Palomo, Pamela Acha, Ana Manzanares, Magnus Tobiasson, Eva Hellström Lindberg, Francisco Solé, Manel Esteller
Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy. Cancer research communications 4 (2) (2024)
Ignacio Campillo-Marcos, Marta Casado-Pelaez, Veronica Davalos, Gerardo Ferrer, Caterina Mata, Elisabetta Mereu, Gael Roué, David Valcarcel, Antonieta Molero, Lurdes Zamora, Blanca Xicoy Cirici, Laura Palomo, Pamela Acha, Ana Manzanares, Magnus Tobiasson, Eva Hellström Lindberg, Francisco Solé, Manel Esteller
Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy. Cancer research communications 4 (2) (2024)
Miquel Martínez-Asensio, Lluís Sàrrias, Gema Gorjón-de-Pablo, Miranda Fernandez-Serrano, Judith Camaló-Vila, Albert Gibert, Raimon Puig de la Bellacasa, Jordi Teixidó, Gael Roué, José Ignacio Borrell, Roger Estrada-Tejedor
Applying Molecular Modeling to the Design of Innovative, Non-Symmetrical CXCR4 Inhibitors with Potent Anticancer Activity. International journal of molecular sciences 25 (17) (2024)
Marcelo Lima Ribeiro, Salvador Sánchez-Vinces, Laura Mondragon, Gael Roué
Epigenetic targets in B- and T-cell lymphomas: latest developments. Therapeutic advances in hematology 14 (2023)
Juliana Carvalho Santos, Núria Profitós-Pelejà, Salvador Sánchez-Vinces, Gael Roué
RHOA Therapeutic Targeting in Hematological Cancers. Cells 12 (3) (2023)
Ignacio Campillo-Marcos, Marta Casado-Pelaez, Veronica Davalos, Gerardo Ferrer, Caterina Mata, Elisabetta Mereu, Gael Roué, David Valcarcel, Antonieta Molero, Lurdes Zamora, Blanca Xicoy Cirici, Laura Palomo, Pamela Acha, Ana Manzanares, Magnus Tobiasson, Eva Hellström Lindberg, Francisco Solé, Manel Esteller
Single-Cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy. Cancer research communications (2023)
Marie Sabatier, Rudy Birsen, Laura Lauture, Sarah Mouche, Paolo Angelino, Jonas Dehairs, Lea Goupille, Ismael Boussaid, Mael Heiblig, Emeline Boet, Ambrine Sahal, Estelle Saland, Juliana Carvalho Santos, Marc Armengol, Miranda Fernandez-Serrano, Thomas Farge, Guillaume Cognet, Federico Simonetta, Corentin Pignon, Antoine Graffeuil, Celine Mazzotti, Herve Avet-Loiseau, Oceane Delos, Justine Bertrand-Michel, Amelie Chedru, Vilma Dembitz, Paolo Gallipoli, Natasha S Anstee, Sun Loo, Andrew H Wei, Martin P Carroll, Armelle Goubard, Rémy Castellano, Yves Collette, François Vergez, Véronique De Mas, Sarah Bertoli, Suzanne Tavitian, Muriel Picard, Christian Recher, Nathalie H Bourgès-Abella, Fanny Granat, Olivier Kosmider, Pierre Sujobert, Benoit Colsch, Carine Joffre, Lucille Stuani, Johannes V Swinnen, Hervé Guillou, Gael Roué, Nawad Hakim, Anne S Dejean, Petros K Tsantoulis, Clément Larrue, Didier Bouscary, Jérome Tamburini, Jean-Emmanuel Sarry
C/EBPa confers dependence to fatty acid anabolic pathways and vulnerability to lipid oxidative stress-induced ferroptosis in FLT3-mutant leukemia. Cancer discovery (2023)
Mélody Caillot, Hadjer Miloudi, Antoine Taly, Nuria Profitós-Pelejà, Juliana C Santos, Marcelo L Ribeiro, Elsa Maitre, Simon Saule, Gael Roué, Fabrice Jardin, Brigitte Sola
Exportin 1-mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin lymphoma. Molecular oncology (2023)
Juliana Carvalho Santos, Núria Profitós-Pelejà, Salvador Sánchez-Vinces, Gael Roué
RHOA Therapeutic Targeting in Hematological Cancers. Cells 12 (3) (2023)
Juliana Carvalho Santos, Núria Profitós-Pelejà, Salvador Sánchez-Vinces, Gael Roué
RHOA Therapeutic Targeting in Hematological Cancers. Cells 12 (3) (2023)
Juliana Carvalho Santos, Núria Profitós-Pelejà, Salvador Sánchez-Vinces, Gael Roué
RHOA Therapeutic Targeting in Hematological Cancers. Cells 12 (3) (2023)
Grégoire Quinet, Wendy Xolalpa, Diana Reyes-Garau, Núria Profitós-Pelejà, Mikel Azkargorta, Laurie Ceccato, Maria Gonzalez-Santamarta, Maria Marsal, Jordi Andilla, Fabienne Aillet, Francesc Bosch, Felix Elortza, Pablo Loza-Alvarez, Brigitte Sola, Olivier Coux, Rune Matthiesen, Gael Roué, Manuel S Rodriguez
Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell Lymphoma. Cancers 14 (4) (2022)
Núria Profitós-Pelejà, Juliana Carvalho Santos, Ana Marin-Niebla, Gael Roué, Marcelo Lima Ribeiro
Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas. Cancers 14 (4) (2022)
Juliana Carvalho Santos, Núria Profitós-Pelejà, Marcelo Lima Ribeiro, Gael Roué
Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma. Cancers 14 (22) (2022)
Marcelo Lima Ribeiro, Diana Reyes-Garau, Meritxell Vinyoles, Núria Profitós-Pelejà, Juliana Carvalho Santos, Marc Armengol, Miranda Fernandez-Serrano, Alícia Sedó Mor, Joan J Bech-Serra, Pedro Blecua, Eva Musulen, Carolina de la Torre, Hari Miskin, Manel Esteller, Francesc Bosch, Pablo Menéndez, Emmanuel Normant, Gael Roué
Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non-Hodgkin Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Marc Armengol, Juliana Carvalho Santos, Miranda Fernandez-Serrano, Núria Profitós-Pelejà, Marcelo Lima Ribeiro, Gael Roué
Immune-Checkpoint Inhibitors in B-Cell Lymphoma. Cancers 13 (2) (2021)
Miranda Fernandez-Serrano, René Winkler, Juliana Carvalho Santos, Marguerite-Marie Le Pannérer, Marcus Buschbeck, Gael Roué
Histone Modifications and Their Targeting in Lymphoid Malignancies. International journal of molecular sciences 23 (1) (2021)
Gael Roué, Brigitte Sola
Management of Drug Resistance in Mantle Cell Lymphoma. Cancers 12 (6) (2020)
Ester Lozano, Tania Díaz, Mari-Pau Mena, Guillermo Suñe, Xavier Calvo, Marcos Calderón, Lorena Pérez-Amill, Vanina Rodríguez, Patricia Pérez-Galán, Gael Roué, M Teresa Cibeira, Laura Rosiñol, Ignacio Isola, Luis-Gerardo Rodríguez-Lobato, Beatriz Martin-Antonio, Joan Bladé, Carlos Fernández de Larrea
Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma. Journal of immunology (Baltimore, Md. : 1950) 200 (8) (2018)
A Esteve-Arenys, J G Valero, A Chamorro-Jorganes, D Gonzalez, V Rodriguez, I Dlouhy, I Salaverria, Elias Campo, D Colomer, A Martinez, G Rymkiewicz, P Pérez-Galán, A Lopez-Guillermo, Gael Roué
The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma. Oncogene 37 (14) (2018)
P Balsas, A Esteve-Arenys, J Roldán, L Jiménez, V Rodríguez, J G Valero, A Chamorro-Jorganes, R Puig de la Bellacasa, J Teixidó, A Matas-Céspedes, A Moros, A Martínez, E Campo, A Sáez-Borderías, J I Borrell, P Pérez-Galán, D Colomer, Gael Roué
Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma. Journal of hematology & oncology 10 (1) (2017)
Carla Solé, Daniel Martínez, Eva Giné, Blanca Gonzalez-Farre, Patricia Pérez-Galán, Giovanna Roncador, Elias Campo, Estela Matutes, Armando López-Guillermo, Gael Roué, Antonio Martinez
Expression of a truncated B lymphocyte-induced maturation protein-1 isoform is associated with an incomplete plasmacytic differentiation program in chronic lymphocytic leukemia. Leukemia & lymphoma 59 (2) (2017)
Simon Body, Anna Esteve-Arenys, Clara Recasens-Zorzo, Xavier Troussard, Gael Roué, Brigitte Sola
A mouse model of disseminated mantle cell lymphoma highlights a lack of activity of estrogen receptor β agonists toward tumor burden. Leukemia & lymphoma 59 (7) (2017)
Simon Body, Anna Esteve-Arenys, Hadjer Miloudi, Clara Recasens-Zorzo, Guergana Tchakarska, Alexandra Moros, Sophie Bustany, Anna Vidal-Crespo, Vanina Rodriguez, Régis Lavigne, Emmanuelle Com, Isolda Casanova, Ramón Mangues, Oliver Weigert, Alejandra Sanjuan-Pla, Pablo Menéndez, Bénédicte Marcq, Jean-Michel Picquenot, Patricia Pérez-Galán, Fabrice Jardin, Gael Roué, Brigitte Sola
Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells. Scientific reports 7 (1) (2017)

Gael Roué.css-eqlu8i{font-size:small;padding-left:4px;} (G Roué, Gael Roue, Gaël Roué)

Publication Activity (10 Years)

Top Topics

Top Venues

Gael Roué (G Roué, Gael Roue, Gaël Roué)